New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
11:09 EDTSYKStryker sees FY13 adjusted EPS $4.20-$4.26, consensus $4.23
Sees FY adjusted EPS growth 10%-12%. Sees FY13 organic sales growth 4.5%-5.5%, consensus $8.99B. Capital allocation plans include: M&A to drive growth, dividend growth, share repurchases. Sees 15% increase in dividend for 2014. Comments from slides that are being presented at the JP Morgan Healthcare Conference.
News For SYK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
10:15 EDTSYKMarathon Patent unit gets favorable early ruling of infringement of '260 patent
Marathon Patent Group (MARA) announced that on July 1, in the patent infringement action filed by its wholly-owned subsidiary, MedTech Development Deutschland GmbH involving the patent EP 1 104 260 B2 the Munich District Court of Germany expressed in its preliminary opinion that the following defendants, Joline GmbH & Co. KG, Signus Medizintechnik GmbH and PanMedical, infringe the '260 patent. The '260 patent had previously been accused of invalidity by Stryker GmbH & Co. KG (SYK). In a nullity hearing held June 19, the five-judge panel at the Federal Patent Court, after carefully considering all facts and arguments brought by Stryker, deliberated and returned with the unrestricted verdict that "All claims are valid."
June 22, 2015
07:43 EDTSYKStryker management to meet with Deutsche Bank
Meeting to be held in Paris on June 22 hosted by Deutsche Bank.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use